Seen On X-itter -- So Take It All With A TRUCKLOAD Of Salt... Incyte To Be Acquired By Merck? I For One Doubt It...

Separately, we can confirm definitively that Merck has boosted its quarterly dividend -- to $0.81/share -- starting in January 2025, though. [That's good news for long term holders, to be sure -- even with the less than stellar tax effect, of paying cash dividends in US companies.]

But let's put this one in the category of. . . not terribly. . . likely.

There would be little reason for Rahway to need to own the whole cow -- when it will always be able to access just the cups of milk it most desires, as a rule.

Yep -- it is a repeated rumor -- based off of a rumor, thus:

. . .Mark Kleinman, Sky News’ City editor, posted on X, the service formerly known as Twitter: “Revealed: Merck, the US-listed pharma group, is the latest industry giant to be linked to a takeover bid for Incyte, with which it collaborates on several drug development projects. Merck has a market cap of $244bn, while Incyte is valued at nearly $15bn. Both refused to comment. . . .”

As we always say -- "never say never. . ." but I am a skeptic here. But do bet on that fat dividend -- now approaching 4% a year. Grin -- now. . . go Buffs, beat the Jayhawks!

नमस्ते